| Literature DB >> 36107598 |
Kok Wang Tan1, Syarifah Noor Nazihah Sayed Masri2, Qurratu Aini Musthafa2, Azrin Mohd Azidin3, Amiruddin Nik Mohamed Kamil3, Azarinah Izaham2, Nadia Md Nor2.
Abstract
BACKGROUND: The serratus plane block is an effective technique for providing analgesia to patients undergoing breast surgery.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36107598 PMCID: PMC9439770 DOI: 10.1097/MD.0000000000030515
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.The CONSORT flow diagram describing patient progress through the study. CONSORT = Consolidated Standards of Reporting Trials.
Patient demographic and surgical data.
| Superficial group (n = 29) | Deep group (n = 29) | ||
|---|---|---|---|
| Age (yr) | 56.5 ± 9.3 | 57.7 ± 9.7 | .61 |
| ASA physical status | .72 | ||
| I | 5 (17.2) | 4(13.8) | |
| II | 24 (82.8) | 25 (86.2) | |
| Weight (kg) | 66.5 ± 14.3 | 63.2 ± 11.9 | .39 |
| Height (cm) | 155.5 ± 4.9 | 155.1 ± 5.30 | .44 |
| BMI (kg/m2) | 27.2 ± 4.9 | 27.14 ± 4.40 | .95 |
| Surgical duration (min) | 86.3 ± 27.9 | 81.4 ± 23.9 | .48 |
| Intraoperative morphine (mg) | 4.8 ± 0.8 | 4.5 ± 0.6 | .08 |
Data expressed as mean ± SD or n (%).
VAS pain score at rest.
| Time frame in hours (h) | Superficial group (n = 29) | Deep group (n = 29) | |
|---|---|---|---|
| 0 | 0.9 ± 1.4 | 1.4 ± 1.6 | .202 |
| 0.5 | 1.7 ± 1.8 | 2.1 ± 1.6 | .357 |
| 1 | 1.4 ± 1.4 | 2.3 ± 1.4 | .019 |
| 2 | 1.1 ± 1.1 | 2.0 ± 1.2 | .005 |
| 3 | 1.1 ± 1.0 | 1.9 ± 1.1 | .003 |
| 4 | 0.9 ± 0.9 | 1.7 ± 1.0 | .001 |
| 8 | 0.8 ± 0.9 | 1.2 ± 1.0 | .099 |
| 12 | 0.7 ± 0.8 | 0.9 ± 0.9 | .293 |
| 16 | 0.5 ± 0.6 | 0.8 ± 0.6 | .099 |
| 20 | 0.4 ± 0.5 | 0.7 ± 0.6 | .065 |
| 24 | 0.4 ± 0.5 | 0.6 ± 0.6 | .108 |
Data expressed in mean ± SD.
denotes significant value.
VAS pain score during movement.
| Time frame in hours | Superficial group (n = 29) | Deep group (n = 29) | |
|---|---|---|---|
| 0 | 1.8 ± 2.0 | 2.0 ± 2.0 | .656 |
| 0.5 | 2.8 ± 1.8 | 3.2 ± 1.7 | .415 |
| 1 | 2.5 ± 1.4 | 3.5 ± 1.3 | .004 |
| 2 | 2.3 ± 1.1 | 3.2 ± 1.1 | .004 |
| 3 | 2.1 ± 1.1 | 2.8 ± 1.1 | .014 |
| 4 | 1.9 ± 1.1 | 2.6 ± 1.0 | .015 |
| 8 | 1.6 ± 0.9 | 2.3 ± 0.9 | .013 |
| 12 | 1.6 ± 0.9 | 1.9 ± 0.8 | .295 |
| 16 | 1.3 ± 0.7 | 1.5 ± 0.7 | .207 |
| 20 | 1.1 ± 0.7 | 1.2 ± 0.6 | .350 |
| 24 | 0.9 ± 0.6 | 1.2 ± 0.6 | .027 |
Data expressed in mean ± SD.
denotes significant value.
Figure 2.Cumulative morphine consumption between superficial versus deep serratus anterior block within 24 hours.
Extent of dermatomal spread.
| Dermatome level | Anterior | Lateral | Posterior | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Superficial group (n = 29) | Deep group (n = 29) | Superficial group (n = 29) | Deep group (n = 29) | Superficial group (n = 29) | Deep group (n = 29) | ||||
| T1 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
| T2 | 17 (58.6) | 9 (31) | .03* | 14 (48) | 9 (31) | .18 | 10 (34.5) | 6 (20.7) | .24 |
| T3 | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - |
| T4 | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - |
| T5 | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - | 29 (100) | 29 (100) | - |
| T6 | 29 (100) | 27 (100) | .15 | 29 (100) | 26 (100) | .07 | 28 (99.6) | 25 (86) | .16 |
| T7 | 25 (86.2) | 5 (17.2) | <.001* | 19 (65) | 4 (13.8) | <.001* | 11 (38) | 2 (6.9) | <.001* |
| T8 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
Data expressed as n (%).